| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |